Center Overview The mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases. The DRC accomplishes this mission through Biomedical Research Core services reflecting the evolving needs of diabetes investigators, vibrant Pilot & Feasibility Programs, and a dynamic Enrichment Program. Now in its 40th year of continuous NIDDK funding, this DRC is located at an outstanding research institution with a longstanding tradition of excellence in diabetes investigation. The WUSM DRC Research Base is organized in four Focus Groups: Metabolic Regulation, Islet Biology & Immunology, Prevention & Epidemiology, and Complications. Investigators from each group participate in DRC programs that address the Center's central scientific theme of enhancing approaches across the translational spectrum. There is compelling evidence that the WUSM DRC is successfully pursuing its mission of supporting and enhancing research, including outstanding productivity as measured by both by scientific publications and peer-reviewed funding in diabetes and related research. Our research strategy will build on these accomplishments by: 1. Creating an environment that supports important as well as innovative research in diabetes and related metabolic disorders; 2. Supporting cutting edge basic and clinical research related to the etiology, pathogenesis, prevention and cure of diabetes; 3. Raising awareness and interest in fundamental and clinical diabetes research in addition to enhancing multidisciplinary approaches to diabetes and its complications; and 4. Translating new knowledge in diabetes to improved treatment of patients with diabetes.

Public Health Relevance

Center Overview Diabetes and related metabolic disorders of obesity, insulin resistance, and metabolic syndrome are complex, systemic conditions involving environmental and genetic influences. The infrastructure and support of the Washington University DRC, as well as its nurturing and collaborative nature, are designed to foster multidisciplinary approaches across the translational spectrum to achieve progress in understanding the pathophysiology of these disorders and in developing an infrastructure for developing new treatments, cures and preventive strategies for diabetes and its complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020579-43
Application #
9851896
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Hyde, James F
Project Start
1996-12-01
Project End
2022-11-30
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
43
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Evans, Trent D; Jeong, Se-Jin; Zhang, Xiangyu et al. (2018) TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis. Autophagy 14:724-726
Lin, Meei-Hua; Miller, Joseph B; Kikkawa, Yamato et al. (2018) Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome. J Am Soc Nephrol 29:1426-1436
Sidhu, Rohini; Mikulka, Christina R; Fujiwara, Hideji et al. (2018) A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum. Biomed Chromatogr 32:e4235
Liu, Hui; Jin, Hongjun; Han, Junbin et al. (2018) Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques. Mol Imaging Biol 20:448-456
Wang, Songyan; Oestricker, Lauren Z; Wallendorf, Michael J et al. (2018) Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. PLoS One 13:e0192441
Turk, John; White, Tayleur D; Nelson, Alexander J et al. (2018) iPLA2? and its role in male fertility, neurological disorders, metabolic disorders, and inflammation. Biochim Biophys Acta Mol Cell Biol Lipids :
Chondronikola, Maria; Magkos, Faidon; Yoshino, Jun et al. (2018) Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial. Obesity (Silver Spring) 26:683-688
Higgins, Cassandra B; Zhang, Yiming; Mayer, Allyson L et al. (2018) Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPAR?. JCI Insight 3:
Cahill, Alison G; Haire-Joshu, Debra; Cade, W Todd et al. (2018) Weight Control Program and Gestational Weight Gain in Disadvantaged Women with Overweight or Obesity: A Randomized Clinical Trial. Obesity (Silver Spring) 26:485-491
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7

Showing the most recent 10 out of 654 publications